MAMaría Cristina Añón

María Cristina Añón

*This is an algorithmically generated author record based on publicly available information.

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


María Cristina Añón has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Agustina Estefania Nardo

    CCT La Plata-CONICET, CICPBA, UNLP, Centro de Investigación y Desarrollo en Ciencia y Tecnología de los Alimentos (CIDCA), 47 y 116, La Plata, 1900, Argentina

    5 shared publications
  • Mabel Cristina Tomás

    Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), CCT La Plata (CONICET), CICPBA, Facultad de Ciencias Exactas (FCE), Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina

    3 shared publications
  • Santiago Suárez

    Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), Comisión de Investigaciones Científicas (CIC-PBA) and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET- CCT La Plata), La Plata, Argentina

    3 shared publications
  • Valeria Anahí Tironi

    Centro de Investigación y Desarrollo en Ciencia y Tecnología de Alimentos (CIDCA) – (CCT La Plata‐CONICET, CICPBA, UNLP) La Plata Buenos Aires Argentina

    3 shared publications
  • Adriana Maite Fernández-Fernández

    Laboratorio de Bioactividad y Nanotecnología de Alimentos, Departamento de Ciencia y Tecnología de Alimentos, Facultad de Química, Universidad de la República, Montevideo, Uruguay

    2 shared publications
  • Adriana Scilingo

    Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), Calle 47 y 116-1900, La Plata, Argentina

    2 shared publications

Latest Publications

  • Open Access

    Bioactive Peptides from Common Beans: A Review

    by Cinthia Edith Sariñana-Núñez, Jose Alberto Gallegos-Infante, Martha Rocio Moreno-Jiménez, Nuria Elizabeth Rocha-Guzmán, Maria Cristina Añón, Alejandro Marangoni

    Bioactive peptides derived from Phaseolus vulgaris represent a promising source for the development of functional ingredients because of the multiple biological activities associated with bean proteins and their hydrolysis products. In this review, a structured literature search was conducted in Scopus, Web of Science, PubMed, and Google Scholar, considering publications from 2011 to 2026 on proteins, hydrolysates, peptide fractions, and peptides derived from P. vulgaris. A comprehensive examination of the methods for production, identification, purification, and characterization was conducted, along with a thorough analysis of the available evidence regarding their antioxidant, antihypertensive, antidiabetic, antimicrobial, and anti-inflammatory properties. Additionally, the potential applications of these substances in functional foods and nutraceuticals were investigated. Hydrolysates and peptide fractions have demonstrated antioxidant capacity and the ability to inhibit enzymes such as angiotensin-converting enzyme, DPP-IV, α-amylase, and α-glucosidase. In addition, studies using diverse models, including enzymatic and cellular assays, and animal models have demonstrated antimicrobial and anti-inflammatory properties. However, the available evidence varies significantly, as numerous studies have been conducted using hydrolysates, peptide mixtures, in vitro assays, or in silico predictions. Additionally, the validation of individual peptides and the available clinical evidence remain limited. Questions also remain regarding the gastrointestinal stability, bioaccessibility, absorption, safety, and behavior of these compounds in different food matrices. In summary, P. vulgaris demonstrates considerable potential as a source for the production of bioactive peptides. However, further research is necessary to validate these peptides individually and assess their stability, safety, dose–response relationships, and in vivo and clinical efficacy.

  • Open Access

    Fermentation Unlocks the Functional Role of Amaranth in Modulating Wheat/Amaranth Sourdough Microbiota and Inhibiting Yeast Growth of Refrigerated Doughs

    by Carolina Dardis, Emiliano Bilbao, María Cristina Añón, Analía G. Abraham

    This study focuses on the development of refrigerated doughs without chemical preservatives to obtain a clean-label product. Sourdough-based strategies were applied to replace conventional preservatives, using both spontaneous flour fermentation and a defined starter culture of Lactiplantibacillus plantarum CIDCA 8327. In parallel, a partial substitution of wheat flour with 7% amaranth flour was evaluated. To monitor fermentation, pH, titratable acidity, and viable microorganism counts were determined in the sourdoughs, along with culture-independent analyses of microbial communities in two independent spontaneously fermented trials. Dough discs prepared from these sourdoughs were analyzed for pH, titratable acidity, and viable microorganisms, and shelf life was determined based on the appearance of visible mould during refrigerated storage. No substantial differences were observed in the physicochemical parameters of the sourdoughs; however, significant differences in microbial communities were detected, influenced by both amaranth addition and wheat flour batch variability. Dough discs prepared with amaranth flour and spontaneous fermentation showed an extended shelf life and lower mould and yeast counts during refrigerated storage. The use of the starter increased shelf life compared to non-fermented doughs but was less effective than spontaneous sourdough with amaranth. Overall, these results highlight the potential of sourdough technology and amaranth flour for developing clean-label refrigerated products.


  • Multitarget Amaranth Peptides: ACE Inhibition, ACE2 Modulation, and Bioavailability Assessment

    by Agustina E. Nardo, Santiago E. Suárez, Susan F. García Fillería, M. Cristina Añón, Alejandra V. Quiroga

    Hypertension, a major risk factor for cardiovascular disease, is largely regulated by the renin-angiotensin system (RAS). This study evaluates the multitarget potential of three amaranth-derived peptides -SFNLPILR, FNLPILR, and AFEDGFEWVSFK- previously identified as renin inhibitors. We assessed their ability to inhibit angiotensin-converting enzyme (ACE), modulate ACE2 activity, and their bioavailability. In vitro assays demonstrated that SFNLPILR and FNLPILR are potent ACE inhibitors (IC₅₀ = 0.075 and 0.055 mM, respectively), with selective or minimal modulation of ACE2 enzymatic activity. Bioinformatic analysis identified encrypted bioactive motifs with known ACE -inhibitory activity within their sequences. Molecular docking revealed that both peptides interact with ACE’s catalytic residues through the LR motif. Additionally, transepithelial transport studies using Caco-2 monolayers confirmed that peptide fragments can cross the intestinal barrier. These findings position SFNLPILR and FNLPILR as promising multifunctional candidates for the development of functional foods aimed at reducing hypertension risk via RAS modulation.


  • Open Access

    Pseudocereal Proteins: Structural and Nutritional Properties, Applications in Food Matrices, In Vitro Digestibility, and Bioactivity

    by Santiago E. Suárez, Francisco Speroni, María Cristina Añón

    One of the trends that has marked the course of the food sector in recent years has been the transition experienced by society from animal‐based proteins to plant‐based proteins. This transition has posed challenges that have not yet been fully resolved and opened up opportunities, such as the study of unconventional protein sources and the emergence of plant‐based foods analogous to traditional products such as meat, milk, and dairy products, and egg products. Within this framework, this manuscript proposes the use of pseudocereal proteins, particularly amaranth, quinoa, and buckwheat, as an alternative protein source with interesting characteristics. Initially, the nutritional, techno‐functional, and bio‐functional aspects of these proteins are discussed, allowing their use in the formulation of different food matrices. Different types of foods formulated with these proteins are then described, delving into the development of beverages. Finally, aspects related to protein digestibility and in vitro methods that allow simulating the gastrointestinal digestion process and the availability possibilities of digestion products at the intestinal level are discussed, and the digestibility characteristics of amaranth, quinoa, and buckwheat proteins and the possibility of obtaining functional foods, particularly beverages, are continued.


  • Antioxidant bioactivity of sunflower protein hydrolysates in Caco-2 cells and in silico structural properties

    by Daniel S. Lopes, Lilian G.V.C. Almeida, Agustina E. Nardo, María Cristina Añón, Lucilene D. dos Santos, Bruno C. Rossini, Cristian M.B. Pinilla, Maria T.B. Pacheco, Fabiana Galland


  • Multitarget Peptides Released by In Vitro Static Gastrointestinal Digestion of an Amaranth Protein Beverage

    by S. E. Suárez, A. Quiroga, A. C. Sabbione, M. Rodríguez, A. E. Nardo, J. Jardin, A. Scilingo, V. Tironi, F. Speroni, M. C. Añón

    Beverages formulated from alternative proteins, such as amaranth, are gaining attraction due to changes in human dietary patterns and environmental concerns like resource use and biodiversity loss. This study focuses on assessing the bioactive peptide release from an amaranth protein beverage. This beverage was subjected to a static simulated gastrointestinal digestion (SGD) protocol to evaluate its bioaccessibility and functional potential. The digests were analyzed for in vitro antihypertensive, antioxidant, and antithrombotic activities. Additionally, digested peptide sequences were identified via LC–MS/MS. The results showed that SGD significantly enhanced the release of bioactive peptides, leading to increased ACE inhibition, antioxidant capacity against ABTS + and AAPH-induced radicals, and antithrombotic effects in clotting assays. LC–MS/MS analysis identified 31 peptides in the digests, ranging from 9 to 21 amino acids, associated with various bioactivities. These findings highlight amaranth proteins potential as a source of functional peptides with health-promoting properties. Further research must be done to isolate and characterize specific peptides for potential therapeutic applications.


  • Dynamic digestion of a high protein beverage based on amaranth: Structural changes and antihypertensive activity

    by Santiago E. Suárez, Hanitra Rabesona, Olivia Ménard, Julien Jardin, Marc Anton, María Cristina Añón


  • Characterization and Bile Acid Binding Capacity of Dietary Fiber Obtained from Three Different Amaranth Products

    by Ana Clara Sabbione, María Cristina Añón, Adriana Scilingo

    Amaranth is a dicotyledonous plant, now considered a health-promoting food. It has been rediscovered by the worldwide food industry, which is increasingly becoming aware of the many uses and benefits provided by amaranth in various food preparations. Amaranth dietary fibers, soluble and insoluble fractions, obtained from flour, protein isolate, and beverage were physicochemically characterized and their potential bile acid binding capacity was evaluated. Primary bile acids binding to fiber might contribute to a hypocholesterolemic effect, while the binding of secondary bile acids could minimize the cytotoxic effect that these metabolites exert on the colon. Amaranth fiber fractions were capable of sequestering cholate, taurocholate, deoxycholate, and bovine bile, with a percentage depending not only on the origin and the type of amaranth fiber evaluated but also on the bile acid studied. Flour fiber and the protein isolate insoluble fractions were the most efficient for binding bile and bile acids with uptake values between 29 and 100% relative to cholestyramine. Moreover, deoxycholate, a hydrophobic secondary bile acid, was the most captured by all the fractions, reaching 100% uptake with total and insoluble fibers of the three amaranth products. These results would suggest that the main effect through which amaranth fiber binds bile acids corresponds to an adsorptive effect mediated by hydrophobic interactions.


  • Bioactive peptides in reformulated food

    by Vanina Ambrosi, María Cristina Añón, Veronica Chamorro, Maria Fernanda Godoy, Gema Nieto, Adriana Pazos, Dario Pighin, Javier Francisco Rey Rodriguez, Adriana Scilingo, Valeria Tironi

  • Open Access

    Spray-Dried Infant Formula Emulsion Stability as Affected by Pre-Heat Treatment and Total Solids Content of the Feed

    by Mariana Rodríguez Arzuaga, Analía G. Abraham, Lilia Ahrné, Marvia G. Pérez Montes, María C. Añón

    Pre-spray-drying processing may affect stability after reconstitution of emulsion-based powders, such as infant formulas. This study aimed to evaluate the effects of pasteurization temperature and total solids (TS) of the feed on the stability of the emulsions obtained from the reconstituted powders. Four infant formula powders (50%-75 °C, 50%-100 °C, 60%-75 °C, and 60%-100 °C) were produced at pilot scale, from emulsions with 50 or 60% TS pasteurized at 75 or 100 °C for 18 s. Both the emulsion feeds and the emulsions from the reconstituted powders (12.5% TS) were analyzed. The results showed that feeds with 60% TS were flocculated, as indicated by the large particle size and viscosity and the pseudoplastic behavior. Light microscopy revealed that, during spray drying, the flocs were disrupted in 60%-100 °C, while the 60%-75 °C emulsion remained flocculated, reducing its stability post-reconstitution. Although all four emulsions were mainly stabilized by caseins, the presence of β-lactoglobulin was also detected at the oil–water interface, in native state in the formulas preheated at 75 °C and aggregated in the formulas preheated at 100 °C. In conclusion, both the degree of whey protein denaturation (resulting from pasteurization) and the TS of the concentrates during infant formula production affected the emulsion stability of the reconstituted powders.